Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Urology. 2016 Jan 6;90:56–61. doi: 10.1016/j.urology.2015.12.040

Table 1.

Demographic and medical characteristics of participants.

Participant Characteristics N=24

Mean (SD)
Age 42.09 (13.23)
BMI 27.43 (5.66)
PANAS negative affect 21.67 9.74
Duration of symptoms in years 7.21 (7.97)
GUPI Score Total, 0-45 23.85 (8.69)
GUPI pain subscale, 0-23, mean (SD) 11.35 (5.03)
GUPI urinary subscale, 0-10 6.33 (2.94)

Race % (n)
White 96 (23)
Asian 4 (1)

Ethnicity % (n)
Non-Hispanic 100 (24)

Education % (n)
High School or GED 4 (1)
Some College 30 (7)
Graduated College 33 (8)
Graduate Degree 33 (8)

Employment % (n)
Employed 83 (20)
Disabled 8 (2)
Retired 4 (1)
Full Time Homemaker 4 (1)

Annual Income/$ % (n)
<10,000 21 (5)
<25,000 4 (1)
<50,000 17 (4)
<100,000 46 (11)
>100,000 12 (3)

Comorbid Conditions % (n)
None 33 (8)
One or More (IBS, Fibromyalgia, TMD, vulvodynia, CFS) 67 (16)

Tricyclic anti-depressants
No 38 (9)
Yes 62 (15)

Opioids
No 75 (18)
Yes 25 (6)

Pentosan Polysulfate
No 33 (8)
Yes 67 (16)

NSAIDs
No 96 (23)
Yes 4 (1)

SSRI/SNRIs
No 88 (21)
Yes 12 (3)

Experiencing flare at baseline visit?
No 67 (16)
Yes 33 (8)

GUPI Score Total, 0-45 23.85 (8.69)

GUPI pain subscale, 0-23, mean (SD) 11.35 (5.03)

GUPI urinary subscale, 0-10 6.33 (2.94)

BMI= Body Mass Index

CFS = Chronic Fatigue Syndrome

IBS= Irritable Bowel Syndrome

GUPI = Genitourinary Pain Index

NSAID = Non-Steroidal Anti-Inflammatory Drug

PANAS = Positive and Negative Affect Scale

TMD= Temporomandibular Disorder

SSRI/SNRI= Selective Serotonin/Norepinephrine Reuptake Inhibitor